David Tapolczay
Chief Executive Officer at CONDUIT PHARMACEUTICALS INC.
Net worth: 6 M $ as of 30/04/2024
Profile
David Joszef Tapolczay founded Sigma Entity One Ltd.
in 2003, where he worked as Chairman & Chief Executive Officer, Nuformix Technologies Ltd.
in 2007, where he worked as Non-Executive Chairman from 2007 to 2020, and Nuformix Plc in 2008, where he worked as Non-Executive Chairman from 2008 to 2020.
Dr. Tapolczay also currently works at Conduit Pharmaceuticals, Inc., as Chief Executive Officer & Director from 2023, Medeor Old Ltd., as Director, Medeor LLP, as Director, and Medeor Pharma Ltd., as Director.
Dr. Tapolczay also formerly worked at The Medical Research Council, as Chief Executive Officer, Lifearc, as Chief Executive Officer from 2008 to 2018, Stylacats Ltd., as Chief Executive Officer, Intelligent OMICS Ltd., as Non-Executive Chairman, Bicycle Therapeutics Plc, as Director, Nanoform Cardiovascular Therapeutics Ltd., as Director, Zeneca Agrochemicals, as Manager in 2013, Cambridge Discovery Chemistry, as Vice President-Research & Development, Glaxo Smithkline Plc, as Senior Manager-Chemical Development, GSK Pharmaceutical Trading SA, as VP-Technology Development from 2005 to 2007, Millenium Group Ltd., as Senior Vice President-Pharmaceutical Sciences, Sigma-Aldrich Co. Ltd., as Chief Scientific Officer, and GSK Group Ltd., as Vice President-Technology Development.
Dr. Tapolczay received his undergraduate degree and doctorate degree from Southampton Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/05/2024 | 2,003,324 ( 2.71% ) | 6 M $ | 30/04/2024 |
David Tapolczay active positions
| Companies | Position | Start |
|---|---|---|
| CONDUIT PHARMACEUTICALS INC. | Chief Executive Officer | 22/09/2023 |
Medeor Pharma Ltd.
 Medeor Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Medeor Pharma Ltd. provides management consulting services. | Director/Board Member | - |
Medeor Old Ltd.
 Medeor Old Ltd. Miscellaneous Commercial ServicesCommercial Services Medeor Old Ltd. provides business support services. The company is headquartered in Cambridge, the United Kingdom. | Director/Board Member | - |
Medeor LLP
 Medeor LLP Miscellaneous Commercial ServicesCommercial Services Medeor LLP provides economic services. The private company is based in Cambridge, UK. and has subsidiaries in United Kingdom. Medeor was founded in 2008. | Director/Board Member | - |
Former positions of David Tapolczay
| Companies | Position | End |
|---|---|---|
Nuformix Technologies Ltd.
 Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Founder | 05/02/2020 |
| NUFORMIX PLC | Founder | 05/02/2020 |
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Chief Executive Officer | 01/12/2018 |
GSK Pharmaceutical Trading SA
 GSK Pharmaceutical Trading SA Pharmaceuticals: MajorHealth Technology GSK Pharmaceutical Trading SA engages in manufacture of pharmaceutical products. The company was founded in 1994 and is headquartered in Brasov, Romania. | Chief Tech/Sci/R&D Officer | 01/04/2007 |
| Glaxo Smithkline Plc /Clinical Pharmacology Unit/ | Corporate Officer/Principal | - |
Training of David Tapolczay
| Southampton Business School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BICYCLE THERAPEUTICS PLC | Health Technology |
| NUFORMIX PLC | Health Technology |
| Private companies | 18 |
|---|---|
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Commercial Services |
| Zeneca Agrochemicals | |
Cambridge Discovery Chemistry
 Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Part of Signature BioScience, Inc., Cambridge Discovery Chemistry provides chemistry research services. Cambridge Discovery Chemistry was acquired by Signature BioScience, Inc. from Millennium Pharmaceuticals, Inc. on July 16, 2001. | Commercial Services |
| Glaxo Smithkline Plc /Clinical Pharmacology Unit/ | Commercial Services |
GSK Pharmaceutical Trading SA
GSK Pharmaceutical Trading SA Pharmaceuticals: MajorHealth Technology GSK Pharmaceutical Trading SA engages in manufacture of pharmaceutical products. The company was founded in 1994 and is headquartered in Brasov, Romania. | Health Technology |
Millenium Group Ltd.
 Millenium Group Ltd. Miscellaneous Commercial ServicesCommercial Services Millenium Group Ltd. provides marketing and communication services. The private company is based in Shipley, UK. and has subsidiaries in United Kingdom. | Commercial Services |
Lifearc
Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Commercial Services |
Sigma Entity One Ltd.
 Sigma Entity One Ltd. Miscellaneous Commercial ServicesCommercial Services Sigma Entity One Ltd. provides solid-form research services to the pharmaceutical and biotech markets. The company was founded by David Tapolczay and Daniel Rowland Cowell on July 16, 2003 and is headquartered in Gillingham, the United Kingdom. | Commercial Services |
Medeor Old Ltd.
Medeor Old Ltd. Miscellaneous Commercial ServicesCommercial Services Medeor Old Ltd. provides business support services. The company is headquartered in Cambridge, the United Kingdom. | Commercial Services |
| GSK Group Ltd. | |
Intelligent OMICS Ltd.
 Intelligent OMICS Ltd. BiotechnologyHealth Technology Intelligent OMICS Ltd. provides analytical and bioinformatics services. Its bioinformatics algorithms are able to identify patients who respond to a particular therapy in new clinical trials or in previous, failed trails. The firm helps drug development companies create new drugs applicable to specific patient sub-groups. The company was founded by Graham Ball and Robert Rees in 2009 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Stylacats Ltd. | |
Medeor LLP
Medeor LLP Miscellaneous Commercial ServicesCommercial Services Medeor LLP provides economic services. The private company is based in Cambridge, UK. and has subsidiaries in United Kingdom. Medeor was founded in 2008. | Commercial Services |
Medeor Pharma Ltd.
Medeor Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Medeor Pharma Ltd. provides management consulting services. | Commercial Services |
| Nanoform Cardiovascular Therapeutics Ltd. | |
| Conduit Pharmaceuticals, Inc. | |
Sigma-Aldrich Co. Ltd.
 Sigma-Aldrich Co. Ltd. Pharmaceuticals: MajorHealth Technology Sigma Aldrich Co. Ltd. engages in the science and technology company. Its products include analytical standards, gas chromatography, spectroscopy, acids and bases, catalysis and inorganics, organometallics, solvents, antibodies, biochemical and reagents, cell biology, microbiology, and polymer sciences. It also offers basic research, product and process development, manufacturing and production, and regulatory compliance services. The company was founded on December 10, 1987 and is headquartered in Gillingham, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- David Tapolczay
